Paper Title

Vaccines Against Sexually Transmitted Infections Promise and Problems of the Magic Bullets for Prevention and Control

Authors

James Dennis Fortenberry

Gregory D. Zimet

Rose M. Mays

Keywords

sti vaccines
sexually transmitted infections
hepatitis b vaccine
neisseria gonorrhea
chlamydia trachomatis
herpes simplex virus (hsv)
human papillomavirus (hpv)
hiv vaccine
vaccine development
disease prevention
public health
immunization
vaccine efficacy
sti control
health economics
infection mechanisms
biomedical research
immunology
vaccine policy
sexual health interventions
emerging vaccines
sexual behavior
adolescent development
sexual interest
partner support
mood and sexual activity
adolescent sexual health
sexual decision-making
risk behavior
sexual satisfaction
condom use
masturbation prevalence
genital self-image
sexual pleasure
female sexual function index (fsfi)
lubricant use
vibrator use
hiv testing
gonorrhea screening
health literacy
relationship status
romantic relationships
masculinity and self-image
testicular cancer and sexuality
sexual abstinence
sexual norms
sti prevention programs
substance use and sexual behavior
sexual health education
psychosocial factors in sexual health
reproductive health interventions

Article Type

Commentaries

Journal

Sexually Transmitted Diseases

Issue

Volume : 27 | Issue : 1 | Page No : 49-52

Published On

January, 2000

Downloads

FULL PDF

CITATION

COPY LINK

Abstract

REALISTIC POSSIBILITIES FOR vaccines against sexually transmitted organisms are growing rapidly. Despite slow progress and disappointments, the remarkable growth in the understanding of the biology of sexually transmitted organisms and the mechanisms by which infection causes disease continue to fuel a great deal of optimism. The only sexually transmitted infection (STI) for which a vaccine is currently available is hepatitis B; however, efforts are underway to develop vaccines for several other sexually transmitted organisms, including Neisseria gonorrhea, Chlamydia trachomatis, herpes simplex virus (HSV), human papilloma virus, and HIV. 1–5 The health and economic costs for these STIs are high, and effective vaccines for these infections have the potential to be invaluable disease-prevention tools.